Laurette Mhlanga, PhD

Research Associate

Research theme: Measuring Infection and Disease

Dr Laurette Mhlanga is Post-Doctoral Research Fellow at Northwestern University she is part of the Malaria Modelling Team at Feinberg School of Medicine in the Department of Preventive Medicine. Laurette is currently leading a project on modelling malaria in urban Nigeria. Laurette is also a research associate at SACEMA and is collaboratively working with SACEMA on compiling publications from her PhD thesis and some COVID related projects namely the blood donor seroprevalence study and wastewater surveillance study.

ORCID ID: 0000-0002-7805-4231

Recent publications

Evidence of HIV incidence reduction in young women, but not in adolescent girls, in KwaZulu-Natal, South Africa
Mhlanga L, Welte A, Grebe PE, Ohler L, van Cutsem G, Huerga H, Conan N

IJID Regions

(2023)

https://doi.org/10.1016/j.ijregi.2023.07.004
The role of wastewater-based epidemiology for SARS-CoV-2 in developing countries: cumulative evidence from South Africa supports sentinel site surveillance to guide public health decision-making
Iwu-Jaja C, Ndlovu NL, Rachida S, Yousif M, Taukobong S, Macheke M, Mhlanga L, van Schalkwyk C, Pulliam JRC, Moultrie T, le Roux W, Schaefer L, Pocock G, Coetzee LZ, Mans J, Bux F, Pillay L, de Villiers D, du Toit AP, Jambo D, Gomba A, Groeninck S, Madgewick N, van der Walt M, Mutshembele A, Berkowitz N, Suchard M, McCarthy K

Science of the Total Environment

(2023)

https://doi.org/10.1016/j.scitotenv.2023.165817
Estimates of prevalence of anti-SARS-CoV-2 antibodies among blood donors in South Africa in March 2022
Bingham JL, Cable R, Coleman C, Glatt TN, Grebe PE, Mhlanga L, Nyano C, Pieterson N, Swanevelder R, Swarts A, Sykes W, van den Berg K, Vermeulen M, Welte A

medRxiv

(2022)

https://doi.org/10.21203/rs.3.rs-1687679/v2
Estimates of prevalence of anti-SARS-CoV-2 antibodies among blood donors in eight provinces of South Africa in November 2021
Cable R, Coleman C, Glatt T, Grebe PE, Mhlanga L, Nyano C, Pieterson N, Swanevelder R, Swarts A, Sykes W, van den Berg K, Vermeulen M, Welte A

medRxiv

(2022)

https://doi.org/10.21203/rs.3.rs-1359658/v1
Smoothing age/time structure of HIV prevalence, for optimal use in synthetic cohort based incidence estimation
Mhlanga L, Grebe PE, Welte A

medRxiv

(2021)

https://doi.org/10.21203/rs.3.rs-959136/v1
SARS CoV-2 infection fatality rate estimates for South Africa
Mhlanga L, Vermeulen M, Grebe PE, Welte A

medRxiv

(2021)

https://doi.org/10.21203/rs.3.rs-707813/v2
Prevalence of anti-SARS-CoV-2 antibodies among blood donors in Northern Cape, KwaZulu-Natal, Eastern Cape, and Free State provinces of South Africa in January 2021
Sykes W, Mhlanga L, Swanevelder R, Glatt TN, Grebe PE, Coleman C, Pieterson N, Cable R, Welte A, van den Berg K, Vermeulen M

Research Square

(2021)

https://doi.org/10.21203/rs.3.rs-233375/v1

Laurette Mhlanga, PhD

Research Associate

Recent publications

Evidence of HIV incidence reduction in young women, but not in adolescent girls, in KwaZulu-Natal, South Africa

The role of wastewater-based epidemiology for SARS-CoV-2 in developing countries: cumulative evidence from South Africa supports sentinel site surveillance to guide public health decision-making

Estimates of prevalence of anti-SARS-CoV-2 antibodies among blood donors in South Africa in March 2022

Estimates of prevalence of anti-SARS-CoV-2 antibodies among blood donors in eight provinces of South Africa in November 2021

Smoothing age/time structure of HIV prevalence, for optimal use in synthetic cohort based incidence estimation

SARS CoV-2 infection fatality rate estimates for South Africa

Prevalence of anti-SARS-CoV-2 antibodies among blood donors in Northern Cape, KwaZulu-Natal, Eastern Cape, and Free State provinces of South Africa in January 2021